ALVO
Price:
$3.92
Market Cap:
$1.22B
Alvotech, along with its various subsidiaries, is dedicated to the global development and manufacturing of biosimilar pharmaceuticals. Its product offerings span key therapeutic categories, encompassing autoimmune conditions, eye disorders, bone diseases, and cancer. A flagship program for the company is AVT02, a high-concentration biosimilar equivalent to Humira. This candidate is designed to address a range of inflammatory illnesses, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and plaque psoriasis. Similarly, AVT04 is a biosimilar version of Stelara, targeting inflammatory conditions such as psoriatic arthritis, Crohn's disease, ulcerative coli...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-06-16
Stock Exchange
NASDAQ
Ticker
ALVO
According to Alvotech’s latest financial reports and current stock price. The company's current PE Ratio is -13.52. This represents a change of -130.68% compared to the average of 44.07 of the last 4 quarters.
The mean historical PE Ratio of Alvotech over the last ten years is 1.29. The current -13.52 PE Ratio has changed -105127.43% with respect to the historical average. Over the past ten years (40 quarters), ALVO's PE Ratio was at its highest in in the March 2026 quarter at 276.61. The PE Ratio was at its lowest in in the June 2021 quarter at -388.54.
Average
1.29
Median
-3.85
Minimum
-15.21
Maximum
51.30
Discovering the peaks and valleys of Alvotech PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 221.89%
Maximum Annual PE Ratio = 51.30
Minimum Annual Increase = -437.35%
Minimum Annual PE Ratio = -15.21
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 51.30 | -437.35% |
| 2024 | -15.21 | 221.89% |
| 2023 | -4.72 | 22.83% |
| 2022 | -3.85 | 11.71% |
| 2021 | -3.44 | 67.38% |
| 2020 | -2.06 | -84.19% |
The current PE Ratio of Alvotech (ALVO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.46
5-year avg
4.82
10-year avg
1.29
Alvotech’s PE Ratio is less than Tilray Brands, Inc. (-0.25), less than Phibro Animal Health Corporation (13.61), less than Evotec SE (-4.26), less than UFP Technologies, Inc. (26.89), less than Progyny, Inc. (32.20), less than Select Medical Holdings Corporation (15.17), less than Amphastar Pharmaceuticals, Inc. (11.00), less than Biohaven Ltd. (-2.39), less than Collegium Pharmaceutical, Inc. (14.15), greater than Harrow Health, Inc. (-109.22),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.25 | $565.73M | |
| 13.61 | $1.29B | |
| -4.26 | $909.28M | |
| 26.89 | $1.85B | |
| 32.20 | $2.04B | |
| 15.17 | $2.05B | |
| 11.00 | $829.39M | |
| -2.39 | $1.44B | |
| 14.15 | $1.09B | |
| -109.22 | $1.60B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alvotech using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alvotech or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Alvotech's PE Ratio?
How is the PE Ratio calculated for Alvotech (ALVO)?
What is the highest PE Ratio for Alvotech (ALVO)?
What is the 3-year average PE Ratio for Alvotech (ALVO)?
What is the 5-year average PE Ratio for Alvotech (ALVO)?
How does the current PE Ratio for Alvotech (ALVO) compare to its historical average?